Shawn Singh
President, Echo Therapeutics, Inc.
Companies
- Vistagen Therapeutics, Inc.President Jun 25, 2025 to now1
- Vistagen Therapeutics, Inc.Board member May 25, 2011 to now2
- Vistagen Therapeutics, Inc.Chief executive officer May 25, 2011 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vistagen Therapeutics, Inc. VTGN75,721 shares3$16.1K at $0.21Jul 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Granted 36,818 shares at $0.19 of Vistagen Therapeutics, Inc.3
- Jun 30, 2025Granted 7,541 shares at $1.70 of Vistagen Therapeutics, Inc.4
- Jun 28, 2024Granted 4,854 shares at $2.96 of Vistagen Therapeutics, Inc.5
- Dec 29, 2023Granted 167 shares at $1.72 of Vistagen Therapeutics, Inc.6
- Jun 30, 2023Granted 167 shares at $1.59 of Vistagen Therapeutics, Inc.7
- Dec 30, 2022Granted 5,000 shares at $0.09 of Vistagen Therapeutics, Inc.8
- Aug 17, 2022Bought 600,000 shares at $0.17 of Vistagen Therapeutics, Inc.9
- Jun 30, 2022Granted 5,000 shares at $0.75 of Vistagen Therapeutics, Inc.10
- May 12, 2022Exercised options 100,000 shares at $1.00 of Vistagen Therapeutics, Inc.11
- Dec 31, 2021Granted 3,623 shares at $1.66 of Vistagen Therapeutics, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jul 1, 2025
- 5SEC EDGARForm 4 filed Jul 2, 2024
- 6SEC EDGARForm 4 filed Jan 3, 2024
- 7SEC EDGARForm 4 filed Jul 5, 2023
- 8SEC EDGARForm 4 filed Jan 3, 2023
- 9SEC EDGARForm 4 filed Aug 18, 2022
- 10SEC EDGARForm 4 filed Jul 15, 2022
- 11SEC EDGARForm 4 filed May 16, 2022
- 12SEC EDGARForm 4 filed Jan 3, 2022